Paper Details

  1. Home
  2. Paper Details

Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies.

Author: EdmonsonJ H, KrookJ E, SuJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

This report explores the therapeutic outcomes of systemic chemotherapy for ovarian cancer in women of different ages, noting an increase in ovarian cancer mortality among American women over 65.
Paper Details　
Original Abstract of the Article :
With a 25% reduction in ovarian cancer mortality rate between 1973 and 1988 among younger American women, the overall control of ovarian cancer appeared to be improving. Unfortunately, American women older than 65 years of age experienced a 16% increase in mortality from this disease during that sam...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/cncr.2820710219

データ提供：米国国立医学図書館（NLM）

Ovarian Cancer: A Desert Storm for Elderly Women

Cancer is a devastating disease, often felt like a relentless desert storm sweeping across lives. This research focuses on the treatment of ovarian cancer, specifically examining the challenges faced by elderly women in combating this disease. The study is a journey through the medical desert, seeking to understand the therapeutic outcomes of ovarian cancer treatment in elderly women.

The study revealed that elderly women with ovarian cancer had a significantly higher mortality rate compared to younger women. This highlights the unique challenges faced by elderly women in battling this disease, urging for further research and development of effective treatment strategies tailored to their specific needs.

A Fight Against the Storm: Tackling Ovarian Cancer in Elderly Women

This research underscores the need for improved treatment options for ovarian cancer in elderly women. This information can guide the development of more effective and personalized therapies, giving hope to those who are facing this challenging diagnosis.

A Desert Oasis of Support: The Fight Against Cancer

Cancer treatment can be a long and difficult journey. It is crucial to have a strong support system of family, friends, and healthcare professionals. Remember, you are not alone in this fight.

Dr.Camel's Conclusion

The fight against cancer is a continuous battle against a formidable desert storm. This research emphasizes the importance of understanding the unique challenges faced by elderly women with ovarian cancer. As we continue to explore new frontiers in cancer treatment, we can strive to create a world where everyone has access to compassionate and effective care.

Date :
  1. Date Completed 1993-02-16
  2. Date Revised 2019-06-20
Further Info :

Pubmed ID

8420684

DOI: Digital Object Identifier

10.1002/cncr.2820710219

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.